1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood conditions

Rilzabrutinib for treating persistent or chronic immune thrombocytopenia in people aged 12 and over [ID6395]

Awaiting development [GID-TA11491] Expected publication date: TBC

  • Project information
  • Project documents

NIHRIO BN: 30538-Rilzabrutinib-for-Immune-Thrombocytopenia-V1.0-NOV2023-NON-CONF.pdf (nihr.ac.uk)